Literature DB >> 8028509

Redundant parasympathetic and sympathoadrenal mediation of increased glucagon secretion during insulin-induced hypoglycemia in conscious rats.

P J Havel1, S J Parry, J S Stern, J O Akpan, R L Gingerich, G J Taborsky, D L Curry.   

Abstract

Both the parasympathetic and sympathoadrenal inputs to the pancreas can stimulate glucagon release and are activated during hypoglycemia. However, blockade of only one branch of the autonomic nervous system may not reduce hypoglycemia-induced glucagon secretion, because the unblocked neural input is sufficient to mediate the glucagon response, ie, the neural inputs are redundant. Therefore, to determine if parasympathetic and sympathoadrenal activation redundantly mediate increased glucagon secretion during hypoglycemia, insulin was administered to conscious rats pretreated with a muscarinic antagonist (methylatropine, n = 7), combined alpha- and beta-adrenergic receptor blockade (tolazoline + propranolol, n = 5) or adrenergic blockade + methylatropine (n = 7). Insulin administration produced similar hypoglycemia in control and antagonist-treated rats (25 to 32 mg/dL). In control rats (n = 9), plasma immunoreactive glucagon (IRG) increased from a baseline level of 125 +/- 11 to 1,102 +/- 102 pg/mL during hypoglycemia (delta IRG = +977 +/- 98 pg/mL, P < .0005). The plasma IRG response was not significantly altered either by methylatropine (delta IRG = +677 +/- 141 pg/mL) or by adrenergic blockade (delta IRG = +1,374 +/- 314 pg/mL). However, the IRG response to hypoglycemia was reduced to 25% of the control value by the combination of adrenergic blockade + methylatropine (delta IRG = +250 +/- 83 pg/mL, P < .01 v control rats). These results suggest that the plasma glucagon response to hypoglycemia in conscious rats is predominantly the result of autonomic neural activation, and is redundantly mediated by the parasympathetic and sympathoadrenal divisions of the autonomic nervous system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8028509     DOI: 10.1016/0026-0495(94)90267-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

Review 1.  Minireview: The role of the autonomic nervous system in mediating the glucagon response to hypoglycemia.

Authors:  Gerald J Taborsky; Thomas O Mundinger
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

Review 2.  The physiology of glucagon.

Authors:  Gerald J Taborsky
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 3.  Alpha cell function in health and disease: influence of glucagon-like peptide-1.

Authors:  B E Dunning; J E Foley; B Ahrén
Journal:  Diabetologia       Date:  2005-08-13       Impact factor: 10.122

4.  Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs.

Authors:  Noelia Rivera; Christopher J Ramnanan; Zhibo An; Tiffany Farmer; Marta Smith; Ben Farmer; Jose M Irimia; Wanda Snead; Margaret Lautz; Peter J Roach; Alan D Cherrington
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

Review 5.  Unravelling innervation of pancreatic islets.

Authors:  Rollie F Hampton; Maria Jimenez-Gonzalez; Sarah A Stanley
Journal:  Diabetologia       Date:  2022-03-29       Impact factor: 10.460

6.  Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.

Authors:  X Fan; Y Ding; S Brown; L Zhou; M Shaw; M C Vella; H Cheng; E C McNay; R S Sherwin; R J McCrimmon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-08       Impact factor: 3.619

7.  Glucagon secretion and autonomic signaling during hypoglycemia in late pregnancy.

Authors:  Kathryn M Canniff; Marta S Smith; D Brooks Lacy; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-03-23       Impact factor: 3.619

Review 8.  The search for the mechanism of early sympathetic islet neuropathy in autoimmune diabetes.

Authors:  G J Taborsky; Q Mei; D J Hackney; T O Mundinger
Journal:  Diabetes Obes Metab       Date:  2014-09       Impact factor: 6.577

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.